Bibliotecas PUC-SP - Busca Integrada

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer

per Alec Kacew, Randy F. Sweis, Randy F. Sweis, Randy F. Sweis
Publicat a Frontiers in Immunology (2020-11-01)

A global method for fast simulations of molecular dynamics in multiscale agent-based models of biological tissues

per Daniel Bergman, Randy F. Sweis, Alexander T. Pearson, Fereshteh Nazari, Trachette L. Jackson
Publicat a iScience (2022-06-01)

Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review

per Arman S. Walia, Randy F. Sweis, Piyush K. Agarwal, Andrew K. Kader, Parth K. Modi
Publicat a Cancers (2021-12-01)

Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms

per Yixuan Wang, Daniel R Bergman, Erica Trujillo, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson
Publicat a Scientific Reports (2023-12-01)

A validated mathematical model of FGFR3‐mediated tumor growth reveals pathways to harness the benefits of combination targeted therapy and immunotherapy in bladder cancer

per Kamaldeen Okuneye, Daniel Bergman, Jeffrey C. Bloodworth, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson
Publicat a Computational and Systems Oncology (2021-06-01)

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy

per Craig Labbate, Ken Hatogai, Ryan Werntz, Walter M. Stadler, Gary D. Steinberg, Scott Eggener, Randy F. Sweis
Publicat a Journal for ImmunoTherapy of Cancer (2019-03-01)

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer

per Randy F. Sweis, Yuanyuan Zha, Lomax Pass, Brian Heiss, Tara Chongsuwat, Jason J. Luke, Thomas F. Gajewski, Russell Szmulewitz
Publicat a Journal for ImmunoTherapy of Cancer (2018-04-01)

Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model

per Daniel R. Bergman, Yixuan Wang, Erica Trujillo, Anthony A. Fernald, Lie Li, Alexander T. Pearson, Randy F. Sweis, Trachette L. Jackson
Publicat a Frontiers in Immunology (2024-03-01)

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy

per Andrea Ziblat, Brendan L. Horton, Emily F. Higgs, Ken Hatogai, Anna Martinez, Jason W. Shapiro, Danny E.C. Kim, YuanYuan Zha, Randy F. Sweis, Thomas F. Gajewski
Publicat a Cell Reports (2024-05-01)

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival

per Guilhem Richard, Anne S. De Groot, Gary D. Steinberg, Tzintzuni I. Garcia, Alec Kacew, Matthew Ardito, William D. Martin, Gad Berdugo, Michael F. Princiotta, Arjun V. Balar, Randy F. Sweis
Publicat a Scientific Reports (2021-05-01)

Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma

per Daniel Huang, Connor Lynch, Lucas M. Serra, Randy F. Sweis, Paul J. Chang, Walter M. Stadler, Russell Z. Szmulewitz, Peter H. O’Donnell, Abhinav Sidana, Scott E. Eggener, Arieh L. Shalhav, Stanley L. Liauw, Sean P. Pitroda
Publicat a Clinical and Translational Radiation Oncology (2024-11-01)

Tumor endothelial inflammation predicts clinical outcome in diverse human cancers.

per Sean P Pitroda, Tong Zhou, Randy F Sweis, Matthew Filippo, Edwardine Labay, Michael A Beckett, Helena J Mauceri, Hua Liang, Thomas E Darga, Samantha Perakis, Sajid A Khan, Harold G Sutton, Wei Zhang, Nikolai N Khodarev, Joe G N Garcia, Ralph R Weichselbaum
Publicat a PLoS ONE (2012-01-01)

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

per Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Publicat a Journal for ImmunoTherapy of Cancer (2019-07-01)

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

per Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Publicat a Journal for ImmunoTherapy of Cancer (2019-05-01)